(Q44659872)

5 December 2017

title

Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial (English)

1 reference

5 December 2017

Sertraline and Cognitive Behavioral Therapy for Depressed Alcoholics: Results of A Placebo-Controlled Trial (English)

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

3 April 2024

1 reference

cognitive behavioral therapy

1 reference

1 reference

4

Konstantin E. Voronin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14624185

3 April 2024

author name string

Ramon Durazo-Arvizu

6

1 reference

5 December 2017

Darlene H. Moak

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14624185

3 April 2024

Raymond F. Anton

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14624185

3 April 2024

Patricia K. Latham

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14624185

3 April 2024

Randolph L. Waid

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14624185

3 April 2024

language of work or name

English

0 references

publication date

1 December 2003

1 reference

full work available at URL

5 December 2017

https://journals.lww.com/10.1097/01.jcp.0000095346.32154.41

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Journal of Clinical Psychopharmacology

3 April 2024

published in

1 reference

5 December 2017

volume

23

1 reference

5 December 2017

issue

6

1 reference

5 December 2017

page(s)

553-562

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

5 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Current perspectives on the pathophysiology of schizophrenia, depression, and anxiety disorders

3 April 2024

3

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey

3 April 2024

5

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

3 April 2024

6

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey

3 April 2024

7

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Prevalence of anxiety, depression, and substance use disorders in an urban general medicine practice

3 April 2024

8

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

The frequency and persistence of depressive symptoms in the alcohol abuser

3 April 2024

9

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Psychopathology as a predictor of treatment outcome in alcoholics.

3 April 2024

10

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

The prevalence of psychiatric disorders in patients with alcohol and other drug problems

3 April 2024

11

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Depression after alcohol treatment as a risk factor for relapse among male veterans

3 April 2024

13

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

The effect of depression on return to drinking: a prospective study.

3 April 2024

14

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Prediction of resumption of drinking in posttreatment alcoholics

3 April 2024

15

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Major depression in a nonclinical sample. Demographic and clinical risk factors for first onset

3 April 2024

16

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Prognostic effect of the variable course of alcoholism on the 10-year course of depression.

3 April 2024

17

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

The disabling nature of comorbid depression among older DUI recipients.

3 April 2024

19

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Multiple Risk Factors Predict Suicide in Alcoholism

3 April 2024

20

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

San Diego Suicide Study. III. Relationships between diagnoses and stressors

3 April 2024

21

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Suicidal ideation among the United States drinking population: results from the National Longitudinal Alcohol Epidemiologic Survey

3 April 2024

22

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Alcoholism and depression in a Swedish female population: co-morbidity and risk factors

3 April 2024

23

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Prospective study of depression and the risk of heavy alcohol use in women

3 April 2024

24

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Do women develop alcoholic brain damage more readily than men?

3 April 2024

25

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in nonhuman primates

3 April 2024

26

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Serotonin, dopamine and GABA involvement in alcohol drinking of selectively bred rats

3 April 2024

27

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

The role of cerebral serotonin in the ethanol preference of animals

3 April 2024

28

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Reduced central serotonin turnover in a subgroup of alcoholics?

3 April 2024

29

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Alcohol and Central Serotonin Metabolism in Man

3 April 2024

30

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Evidence for a defect in tryptophan metabolism in chronic alcoholism

3 April 2024

31

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems

3 April 2024

33

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics

3 April 2024

34

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Selective serotonin reuptake inhibitors in affective disorders--I. Basic pharmacology

3 April 2024

35

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial

3 April 2024

36

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression

3 April 2024

37

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial

3 April 2024

38

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial

3 April 2024

39

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Double-blind clinical trial of sertraline treatment for alcohol dependence

3 April 2024

40

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Psychotherapeutic considerations in pharmacological trials

3 April 2024

42

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

A rating scale for depression

3 April 2024

43

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers.

3 April 2024

44

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description

3 April 2024

46

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Validity of the SCID in substance abuse patients.

3 April 2024

47

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

The family history method using diagnostic criteria. Reliability and validity

3 April 2024

48

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

An Inventory for Measuring Depression

3 April 2024

49

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies

3 April 2024

50

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Alcohol dependence syndrome: measurement and validation

3 April 2024

51

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

The reliability of Form 90: an instrument for assessing alcohol treatment outcome

3 April 2024

52

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

The reliability of a timeline method for assessing normal drinker college students' recent drinking history: utility for alcohol research

3 April 2024

53

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

The effect of drinking intensity and frequency on serum carbohydrate-deficient transferrin and gamma-glutamyl transferase levels in outpatient alcoholics.

3 April 2024

54

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Ensuring balanced distribution of prognostic factors in treatment outcome research.

3 April 2024

55

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

New methodologies for pharmacological treatment trials for alcohol dependence

3 April 2024

56

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Riboflavin as a tracer of medication compliance

3 April 2024

57

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. Project MATCH Research Group

3 April 2024

58

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Modelling covariance structure in the analysis of repeated measures data

3 April 2024

60

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Factor structure and predictive validity of the Obsessive Compulsive Drinking Scale

3 April 2024

62

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

3 April 2024

63

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000095346.32154.41

3 April 2024

Identifiers

1 reference

5 December 2017

1 reference